Penumbra, Inc. 0P8.F Stock
Penumbra, Inc. Price Chart
Penumbra, Inc. 0P8.F Financial and Trading Overview
Penumbra, Inc. stock price | 203.5 EUR |
Previous Close | 308 EUR |
Open | 308 EUR |
Bid | 306 EUR x 6100 |
Ask | 308 EUR x 6100 |
Day's Range | 308 - 308 EUR |
52 Week Range | 110 - 312 EUR |
Volume | 17 EUR |
Avg. Volume | 1 EUR |
Market Cap | 11.89B EUR |
Beta (5Y Monthly) | 0.517253 |
PE Ratio (TTM) | 2053.3333 |
EPS (TTM) | 2.16 EUR |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 324.83 EUR |
0P8.F Valuation Measures
Enterprise Value | 11.89B EUR |
Trailing P/E | 2053.3333 |
Forward P/E | 193.7107 |
PEG Ratio (5 yr expected) | 13.82 |
Price/Sales (ttm) | 13.44094 |
Price/Book (mrq) | 11.497256 |
Enterprise Value/Revenue | 13.444 |
Enterprise Value/EBITDA | 285.844 |
Trading Information
Penumbra, Inc. Stock Price History
Beta (5Y Monthly) | 0.517253 |
52-Week Change | 171.92% |
S&P500 52-Week Change | 20.43% |
52 Week High | 312 EUR |
52 Week Low | 110 EUR |
50-Day Moving Average | 273.08 EUR |
200-Day Moving Average | 223.67 EUR |
0P8.F Share Statistics
Avg. Volume (3 month) | 1 EUR |
Avg. Daily Volume (10-Days) | 1 EUR |
Shares Outstanding | 38.25M |
Float | 36.34M |
Short Ratio | N/A |
% Held by Insiders | 3.91% |
% Held by Institutions | 91.30% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | 0.73% |
Operating Margin (ttm) | 2.04% |
Gross Margin | 63.17% |
EBITDA Margin | 4.70% |
Management Effectiveness
Return on Assets (ttm) | 0.84% |
Return on Equity (ttm) | 0.65% |
Income Statement
Revenue (ttm) | 884.64M EUR |
Revenue Per Share (ttm) | 23.29 EUR |
Quarterly Revenue Growth (yoy) | 18.39% |
Gross Profit (ttm) | 535.21M EUR |
EBITDA | 41.61M EUR |
Net Income Avi to Common (ttm) | 6.48M EUR |
Diluted EPS (ttm) | 0.15 |
Quarterly Earnings Growth (yoy) | 10738.00% |
Balance Sheet
Total Cash (mrq) | 199.1M EUR |
Total Cash Per Share (mrq) | 5.21 EUR |
Total Debt (mrq) | 233.52M EUR |
Total Debt/Equity (mrq) | 22.79 EUR |
Current Ratio (mrq) | 5.375 |
Book Value Per Share (mrq) | 26.789 |
Cash Flow Statement
Operating Cash Flow (ttm) | -38018000 EUR |
Levered Free Cash Flow (ttm) | -63489000 EUR |
Profile of Penumbra, Inc.
Country | Germany |
State | CA |
City | Alameda |
Address | One Penumbra Place |
ZIP | 94502 |
Phone | 510 748 3200 |
Website | https://www.penumbrainc.com |
Industry | Medical Devices |
Sector(s) | Healthcare |
Full Time Employees | 3900 |
Penumbra, Inc., together with its subsidiairies, designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device, and Penumbra ENGINE brands, as well as components and accessories; neurovascular embolization coiling systems to treat patients with various sizes of aneurysms and other neurovascular lesions under the Penumbra Coil 400, POD400, PAC400, and Penumbra SMART Coil brand names; and neurovascular access systems designed to provide intracranial access for use in a range of neurovascular therapies under the Neuron, Neuron MAX, Select, BENCHMARK, BMX96, DDC, SENDit, and PX SLIM brands. It also provides neurosurgical aspiration tools for the removal of tissue and fluids under the Artemis Neuro Evacuation Device brand; aspiration-based thrombectomy systems for vascular applications under the Indigo System, Lightning, and CAT RX brand; and detachable embolic coil systems for peripheral embolization under the Ruby Coil and Ruby LP brand names. In addition, the company offers microcatheter for the delivery of detachable coils and occlusion devices under the LANTERN brand; and POD (Penumbra Occlusion Device) brand, as well as immersive 3D computer-based technology platform under the Real Immersive System brand; and a complementary device for use with Ruby Coil and POD for vessel occlusion under the Packing Coil and Packing Coil LP brands. The company sells its products through direct sales organizations and distributors. Penumbra, Inc. was incorporated in 2004 and is headquartered in Alameda, California.
Q&A For Penumbra, Inc. Stock
What is a current 0P8.F stock price?
Penumbra, Inc. 0P8.F stock price today per share is 203.5 EUR.
How to purchase Penumbra, Inc. stock?
You can buy 0P8.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Penumbra, Inc.?
The stock symbol or ticker of Penumbra, Inc. is 0P8.F.
Which industry does the Penumbra, Inc. company belong to?
The Penumbra, Inc. industry is Medical Devices.
How many shares does Penumbra, Inc. have in circulation?
The max supply of Penumbra, Inc. shares is 38.7M.
What is Penumbra, Inc. Price to Earnings Ratio (PE Ratio)?
Penumbra, Inc. PE Ratio is 94.21296000 now.
What was Penumbra, Inc. earnings per share over the trailing 12 months (TTM)?
Penumbra, Inc. EPS is 2.16 EUR over the trailing 12 months.
Which sector does the Penumbra, Inc. company belong to?
The Penumbra, Inc. sector is Healthcare.